Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne
© Selway et al.; licensee BioMed Central Ltd. 2013
Received: 22 March 2013
Accepted: 28 August 2013
Published: 6 September 2013
Skip to main content
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.
© Selway et al.; licensee BioMed Central Ltd. 2013
Received: 22 March 2013
Accepted: 28 August 2013
Published: 6 September 2013
Acne is a common disorder of the human pilosebaceous unit, yet the mechanisms underlying hyperkeratinisation and subsequent inflammation (comedogenesis) remain to be determined, although cutaneous pathogens are implicated. Previously, it was reported that the release of the cytokine interleukin-1α (IL-1α) by keratinocytes of the sebaceous duct was pivotal in the life cycle of the comedone, mediating both its development and its spontaneous resolution. Toll-like receptors are a family of molecules that recognise pathogen associated molecular patterns (PAMPs) presented by microorganisms, initiating a signalling cascade terminating in the release of antimicrobial compounds and cytokines.
We used ex vivo sebaceous gland and primary monolayer keratinocyte culture, alongside ELISAs, immunohistochemistry, Western blotting and RT-PCR to investigate the contribution of TLR activation to acne pathogenesis.
We found TLR2 to be expressed in basal and infundibular keratinocytes, and sebaceous glands, and its activation provoked the release of IL-1α from primary human keratinocytes in vitro. The exposure of microdissected human sebaceous glands to PAMPs specific for TLR2 in vitro resulted in a pattern of IL-1α like cornification after seven days of exposure.
TLR activation and secretion of IL-1α from keratinocytes may be initiating steps in comedogenesis and, therefore, critical to the pathophysiology of acne.
Acne is characterized by the formation of comedones, but the etiology of these lesions remains unclear, although cutaneous pathogens are most likely involved. High levels of the pro-inflammatory cytokine IL-1α were reported in acne lesions in vivo, and previous work revealed that exposure of isolated infundibula and pilosebaceous units to IL-1α in vitro induced comedone formation [2, 3]. Because comedone formation reflects the development of infundibular epidermal scaling, this finding is important because it suggests that IL-1α, whose role in the epidermis remains to be fully elucidated, is a mediator of scaling in inflammatory skin disease. We sought to establish a link between cutaneous flora, the release of IL-1α and the acne life-cycle.
The epidermis provides the first line of defense against invasion by pathogens. Whilst the epidermis contains antigen-presenting Langerhans cells of the adaptive immune system , keratinocytes also have inherent mechanisms to combat infection. This innate immunity is a remnant of an ancient host defense mechanism shared with lower organisms, pre-dating adaptive immunity. The activation of the prototypical innate Drosophila receptor Toll is central to this innate response, leading to the release of antifungal factors . A related family of Toll-like receptors (TLRs) are widely expressed in mammalian tissues, particularly epithelia, and growing body of research indicates the importance of innate immunity in cutaneous pathology [6–9]. Eleven mammalian Toll homologues have been characterised to date, each recognizing a discrete set of invariant moieties associated with infectious agents called pathogen associated molecular patterns, or PAMPs . Notable PAMPs include peptidoglycan (PGN) a component of the coats of gram-positive bacteria (including P. acnes), lipopolysaccharide (LPS) from gram-negative bacteria, or unmethylated CpG DNA characteristic of viruses, which activate TLR2, TLR4 and TLR9 respectively [reviewed in ]. PAMPs are recognised by a leucine-rich extracellular TLR domain, initiating a signal transduction cascade via an intracellular interleukin-1 receptor (IL-1R)-like region, characteristically leading to the release of antibacterial compounds (β-defensins and reactive oxygen species) and cytokines (including IL-1α) via an NFκB-dependent mechanism [10, 11].
There is much speculation regarding the source of infundibular IL-1α in acne, and there are reports of release either by keratinocytes [3, 12, 13] or by the cells of the immune system [14, 15]. Since IL-1α release is a consequence of TLR signaling in many cell types including keratinocytes [10, 13], we wished to investigated if the exposure of sebaceous glands maintained ex vivo to PAMPs induced hypercornification via the TLR-stimulated release of IL-1α.
All materials were obtained from Sigma-Aldrich Ltd. (Poole, UK), unless otherwise stated.
Normal human mid-line chest skin was obtained from patients aged 48 to 76 yr undergoing cardiothoracic surgery at Papworth Hospital (Huntington, UK). Sebaceous glands were microdissected as previously described . Both University of Buckingham School of Science and Medicine Ethical Committee approval and informed patient consent were obtained. Tissues were either formalin fixed and paraffin embedded for subsequent histological evaluation, or used immediately for organ culture.
Normal human epidermal keratinocytes (NHEK, Invitrogen, Paisley, UK) were maintained in keratinocyte serum free medium (Invitrogen, Paisley, UK) as standard. Sebaceous glands were maintained ex vivo on gelatine sponges (Gelfoam, Upjohn, Kalamazoo, MI, USA) at 37°C in a humidified 5% CO2: 95% air environment for 7 days in William’s E medium (without phenol red), supplemented with 2 mM L-glutamine, 500 ng/ml hydrocortisone, sodium selenite (20 μM), triiodothyronine (10 nM), 1% trace element mix (all supplements from Invitrogen), 11.1 mM glucose, 10 μg/ml bovine pituitary extract, 100 U/ml penicillin, 100 μg/ml streptomycin and 2.5 μg/ml amphotericin B. TLR agonists used in the organ culture experiments were LPS (Cat. No. L8643), PGN ( Cat. No. 77140), and LTA (Cat. No. L2515). Sebaceous glands were incubated in the presence or absence of IL-1α (1 ng/μl), or relevant PAMPs (25 μg/ml). Antibodies raised against human TLR2 and TLR4 were obtained from HyCult Biotechnology bv (Uden, Netherlands) and used at 100 μg/ml to block the effect of the PAMPs. Organ culture experiments consisted of at least 3 biological replicates per treatment group, with at least three glands studied from each donor.
RNA was prepared from whole sebaceous glands or cultured cells with TRI-reagent, and 1 μg total RNA was used in first strand cDNA synthesis with random hexamers (Pharmacia) according to the manufacturers’ recommendations. 35 cycles of PCR (each of 94°C, 55°C and 72°C for 1 min) were performed as standard using specific primers for TLR2 (TLR2_FOR- GATGCCTACTGGGTGGACAA; TLR2_REV- TTGACAGCTCAGGGATGTTG) (MWG-Biotech, Ebersberg, Germany).
4 μm paraffin sections of chest skin derived from 10 different male donors were dewaxed in Histoclear (National diagnostics, Hull, UK) and rehydrated in graded ethanols prior to incubation with an anti-TLR2 goat polyclonal antibody at 37°C overnight at (sc-8690 used at 20 μg/ml, Santa Cruz, La Jolla, USA). Specificity was evaluated by co-incubating primary antisera with a five-fold excess of a Santa Cruz blocking peptide (sc-8690 P, Santa Cruz, La Jolla, USA). Following incubation with an appropriate HRP-conjugated secondary antiserum for 45 minutes at room temperature, slides were developed with ImmPACT DAB peroxidase substrate (Vector Laboratories, Peterborough, UK) according to the manufacturer’s recommendations and counterstained with haematoxylin before clearing in Histoclear and mounting in VectaMount hardset mountant (Vector Laboratories, Peterborough, UK). Tissue sections were stained in triplicate and samples from different individuals were stained contemporaneously to facilitate comparison.
IL-1α levels in 100 μl medium collected after 2 hr treatment of pre-confluent NHEK with PGN (10 μg/ml) was assayed by ELISA (MESOScale Discovery, Gaithersburg, MD) according to the manufacturer’s recommendations. In order to assess specificity, NHEK incubated with PGN and a ten-fold excess (by mass) of a TLR2 neutralising antibody were included in the study. All assays were performed in triplicate.
Pre-confluent primary keratinocytes were homogenised in RIPA buffer (150 mM NaCl, 10 mM Tris-Cl pH7.2, 5 mM EDTA, 0.1% SDS, 1.0% Triton-X100, 1.0% sodium deoxcycholate, 1 mM phenylmethylsulphonylfluoride). 20 μg protein was electrophoresed through a 4-12% pre-cast bis-tris NuPage mini-gel (Invitrogen) and transferred to PVDF membranes (Millipore) by wet electroblotting as standard. Immunodetection was performed using an anti-IκB polyclonal antibody (used at 1:1000 dilution, Santa Cruz) and chemiluminescent detection (WesternBreeze, Invitrogen) as recommended.
TLR2 immunoreactivity was evaluated in tissue isolated from ten individuals, and representative patterns are shown in Figure 1B. In the interfollicular epidermis, expression was consistently most abundant in the basal layer, and this predominantly basal pattern of immunolocalisation was also observed in infundibular keratinocytes. The specificity of immunoreactivity was confirmed by co-incubation with a specific TLR2 antigen blocking peptide, following which no staining was observed (Figure 1B).
Western blotting was used to determine the degradation of the NFκB repressor IκB in response to PAMP stimulation of NHEK. A reduction in IκB signal in response to PGN treatment was detected after two hours of PAMP incubation, an effect that was inhibited in the presence of the TLR2 blocking antibody (Figure 2B).
The skin is also colonised by gram-negative commensals such as P. aeruginosa (which act via TLR4 activation) and the exposure of isolated glands to LPS also specifically-increased cornification, which was blocked following co-incubation with an excess of a TLR4 neutralising antibody. All images are representative of three different experiments.
The expression of functional TLRs in both interfollicular and infundibular human keratinocytes is consistent with an innate role for these cells in the sensing of, and response to, bacterial pathogens . The majority of cutaneous pathogens are gram-positive and, therefore, likely to initiate a response via TLR2. As P. acnes exposure leads to increases in TLR2 (as well as TLR4) expression in NHEK, and TLR2 expression was reported within acne lesions in situ, we choose to further investigate the role of this receptor in keratinocyte and sebaceous gland function.
Although keratinocytes are known to express TLR2, the precise compartmental localization of this receptor in the epidermis is not clear [18–22]. Our observation of predominantly basal localization of TLR2 in a range of human skin samples agrees with the reports of both Baker et al. and Curry et al., but some variation between individuals, or indeed studies, would be expected (as reported by Pivarsci et al. and Jugeau et al.) as these receptors are readily induced, notwithstanding any genetic differences .
Viable stationary-phase P. acnes directly-activates NHEK via TLR2, stimulating IL-1α release . As the treatment of NHEK with LTA and PGN was reported to trigger NFκB activation via TLR2, in turn regulating the release of the potent chemokine IL-8 [17, 21], it is rational to investigate the role of PAMPs in the pathogenesis of acne. We found that the treatment of primary cultures of keratinocytes with TLR2 agonists provoked the release of IL-1α, confirming our hypothesis and previously published results [17, 21]. This is likely to be a post-translational event as previous observations indicated that stimulation with micro-organisms (including P. acnes) was unable to stimulate the synthesis of IL-1α in keratinocytes [24, 25]. In addition, in our organ-maintained pilosebaceous units, we were able to show that PAMP treatment led to a pattern of hypercornification similar to that created by IL-1α exposure (and, indeed, that seen in comedones in situ), via both TLR2- and TLR4-dependent mechanisms. Furthermore, normal morphology was maintained when PAMP activity was neutralized with specific TLR blocking antibodies. This suggests that PAMPs mediate their effects on sebaceous glands via TLRs. The presence of a TLR2-dependent innate immune response in sebocytes was previously documented [25, 26], but the role of IL-1α, in addition to that of lipid mediators such as free fatty acids, is complex.
We recognize that the removal of organs from their natural environment in our ex vivo model does not allow us to investigate the contribution of the immune system. This is an important consideration as the response triggered by skin resident immune cells could modulate the effect of PAMPs through both TLR-dependent and TLR-independent mechanisms. That we were able to provoke a response in normal human skin (or at least skin without frank evidence of acne), which is associated with a low level of infiltrating immune cells, suggest that our model is able to recapitulate comedogenesis, at least in part. One could also investigate the role of TLR agonism in human sebocyte monolayer culture, or in sebaceous glands isolated from individuals with acne, but we feel that our model provides a good compromise between biological relevance and feasibility.
The role of pro-inflammatory cytokines in enhanced lipogenesis and acne pathogenesis is complex [24, 25, 27–32]. Increased sebum levels in adolescents, perhaps exacerbated by elevated free fatty acid availability resulting from exposure to Western diets , may promote cutaneous P. acnes colonization . Furthermore, other hormonal mediators may contribute to a ‘perfect storm’ of acne susceptibility. For example, elevated IGF1 signaling can suppress the transcription of anti-microbial peptides , thereby priming the innate immune response. Thus, enhanced sebum levels, high IGF1 signaling and free fatty acid availability could act in concert to create a pro-inflammatory state primed for comedogenesis . Prominent in this pro-inflammatory state is IL-1α [17, 21], as well as other cytokines such as TNFα [29, 30].
This work was funded in part by a grant from Pfizer Global Research and Development. We are indebted to members of the Clore Laboratory, in particular Mike Cawthorne, Claire Stocker and Ed Wargent for continued support and helpful advice. We are grateful to Jean Chadderton and theatre colleagues at Papworth Hospital, Papworth, UK for providing human tissue.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.